FTC: Pharmacy managers inflated drug prices by $7.3 billion

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S. Federal Trade Commission said on Tuesday.

See the original article at: Honolulu Star-Advertiser